Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2023 Earnings Call Transcript
Ginkgo Bioworks Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.09 EPS, expectations were $-0.09. Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings Inc. (DNA)
Market is closed
News
- 1 - 10
- Next >>
12 Best NYSE Penny Stocks To Buy
Markets wavered as latest data showed inflation in January 2024 was hotter-than-expected.
5 Hot Healthcare Stocks To Buy Now
In this article, we will be taking a look at 5 hot healthcare stocks to buy now.
Ark Invest Stock Portfolio: 16 Biggest Positions
In this article, we discuss the 16 biggest positions in the ARK Invest portfolio.
12 Best Genomics Stocks To Buy Now
In this piece, we will take a look at the 12 best genomics stocks to buy now.
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q3 2023 Earnings Call Transcript
Megan LeDuc: Good evening. I'm Megan LeDuc, Manager of Investor Relations at Ginkgo Bioworks. I'm joined by Jason Kelly, our Co-Founder and CEO; and Mark Dmytruk, our CFO.
15 Best ARK Stocks To Buy Now
Cathie Wood’s flagship ARK Innovation ETF made a roaring comeback earlier this year when investors’ risk appetite increased and growth stocks rebounded.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
5 Best High Risk Penny Stocks to Buy Now
Ranking 5th in our list of the best high risk penny stocks is Gossamer Bio, Inc. (NASDAQ:GOSS), a biopharma company working on treatments in immunology, inflammation, and oncology segments.
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
- 1 - 10
- Next >>
Billionaire Hedge Funds
